2,061
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration

, , , , , , & show all
Pages 555-561 | Received 24 Feb 2011, Accepted 08 Jun 2011, Published online: 04 Aug 2011

References

  • Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W. (2006). Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release, 111, 107–116.
  • Collister KA, Albensi BC. (2005). Potential therapeutic targets in the NF-kappaB pathway for Alzheimer’s disease. Drug News Perspect, 18, 623–629.
  • Gao X, Chen J, Tao W, Zhu J, Zhang Q, Chen H, Jiang X. (2007). UEA I-bearing nanoparticles for brain delivery following intranasal administration. Int J Pharm, 340, 207–215.
  • Gao X, Tao W, Lu W, Zhang Q, Zhang Y, Jiang X, Fu S. (2006). Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials, 27, 3482–3490.
  • Gao X, Wu B, Zhang Q, Chen J, Zhu J, Zhang W, Rong Z, Chen H, Jiang X. (2007). Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration. J Control Release, 121, 156–167.
  • Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci, 11, 1–18.
  • Kabanov AV, Gendelman HE. (2007). Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog Polym Sci, 32, 1054–1082.
  • Kissel T, Werner U. (1998). Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. J Control Release, 53, 195–203.
  • Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. (2002). Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target, 10, 317–325.
  • Li J, Wu H, Hong J, Xu X, Yang H, Wu B, Wang Y, Zhu J, Lai R, Jiang X, Lin D, Prescott MC, Rees HH. (2008). Odorranalectin is a small peptide lectin with potential for drug delivery and targeting. PLoS One, 3, e2381.
  • Liu WK, Sze SC, Ho JC, Liu BP, Yu MC. (2004). Wheat germ lectin induces G2/M arrest in mouse L929 fibroblasts. J Cell Biochem, 91, 1159–1173.
  • Luessen HL, de Leeuw BJ, Langemeyer MW, de Boer AB, Verhoef JC, Junginger HE. (1996). Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res, 13, 1668–1672.
  • Lundh B, Brockstedt U, Kristensson K. (1989). Lectin-binding pattern of neuroepithelial and respiratory epithelial cells in the mouse nasal cavity. Histochem J, 21, 33–43.
  • Mei H, Shi W, Pang Z, Wang H, Lu W, Jiang X, Deng J, Guo T, Hu Y. (2010). EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery. Biomaterials, 31, 5619–5626.
  • Ntziachristos V, Bremer C, Weissleder R. (2003). Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol, 13, 195–208.
  • Pardridge WM. (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRx, 2, 3–14.
  • Pellier V, Astic L. (1994). Histochemical and immunocytochemical study of the migration of neurons from the rat olfactory placode. Cell Tissue Res, 275, 587–598.
  • Seki T, Kanbayashi H, Chono S, Tabata Y, Morimoto K. (2007). Effects of a sperminated gelatin on the nasal absorption of insulin. Int J Pharm, 338, 213–218.
  • Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ. (1998). Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res, 15, 270–275.
  • Tyler CM, Federoff HJ. (2006). CNS gene therapy and a nexus of complexity: systems and biology at a crossroads. Cell Transplant, 15, 267–273.
  • Vila A, Sanchez A, Evora C, Soriano I, McCallion O, Alonso MJ. (2005). PLA-PEG particles as nasal protein carriers: the influence of the particle size. Int J Pharm, 292, 43–52.
  • Witschi C, Mrsny RJ. (1999). In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res, 16, 382–390.
  • Yamagishi M, Nakamura H, Takahashi S, Nakano Y, Iwanaga T. (1989). Olfactory receptor cells: immunocytochemistry for nervous system-specific proteins and re-evaluation of their precursor cells. Arch Histol Cytol, 52 Suppl, 375–381.
  • Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W. (2010). Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release, 143, 136–142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.